These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38814532)

  • 21. Effect of a Home-Base Core Stability Exercises in Hereditary Ataxia. A Randomized Controlled Trial. A Pilot Randomized Controlled Trial.
    Cabanas-Valdés R; Fernández-Lago H; Peláez-Hervás S; Serra-Rusiñol L; López-de-Celis C; Masbernat-Almenara M
    Mov Disord Clin Pract; 2024 Jun; 11(6):666-675. PubMed ID: 38563436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease.
    Rupprechter S; Morinan G; Peng Y; Foltynie T; Sibley K; Weil RS; Leyland LA; Baig F; Morgante F; Gilron R; Wilt R; Starr P; Hauser RA; O'Keeffe J
    Sensors (Basel); 2021 Aug; 21(16):. PubMed ID: 34450879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of SARA
    Grobe-Einsler M; Taheri Amin A; Faber J; Schaprian T; Jacobi H; Schmitz-Hübsch T; Diallo A; Tezenas du Montcel S; Klockgether T
    Mov Disord; 2021 May; 36(5):1242-1246. PubMed ID: 33433030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prodromal Spinocerebellar Ataxia Type 2 Subjects Have Quantifiable Gait and Postural Sway Deficits.
    Velázquez-Pérez L; Rodriguez-Labrada R; González-Garcés Y; Arrufat-Pie E; Torres-Vega R; Medrano-Montero J; Ramirez-Bautista B; Vazquez-Mojena Y; Auburger G; Horak F; Ziemann U; Gomez CM
    Mov Disord; 2021 Feb; 36(2):471-480. PubMed ID: 33107647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principal component analysis for ataxic gait using a triaxial accelerometer.
    Matsushima A; Yoshida K; Genno H; Ikeda SI
    J Neuroeng Rehabil; 2017 May; 14(1):37. PubMed ID: 28464831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
    Romano S; Coarelli G; Marcotulli C; Leonardi L; Piccolo F; Spadaro M; Frontali M; Ferraldeschi M; Vulpiani MC; Ponzelli F; Salvetti M; Orzi F; Petrucci A; Vanacore N; Casali C; Ristori G
    Lancet Neurol; 2015 Oct; 14(10):985-91. PubMed ID: 26321318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes.
    Vogel AP; Folker J; Poole ML
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008953. PubMed ID: 25348587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurorehabilitation Improves the Motor Features in Prodromal SCA2: A Randomized, Controlled Trial.
    Velázquez-Pérez L; Rodríguez-Diaz JC; Rodríguez-Labrada R; Medrano-Montero J; Aguilera Cruz AB; Reynaldo-Cejas L; Góngora-Marrero M; Estupiñán-Rodríguez A; Vázquez-Mojena Y; Torres-Vega R
    Mov Disord; 2019 Jul; 34(7):1060-1068. PubMed ID: 30958572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Objective home-based gait assessment in spinocerebellar ataxia.
    Subramony SH; Kedar S; Murray E; Protas E; Xu H; Ashizawa T; Tan A
    J Neurol Sci; 2012 Feb; 313(1-2):95-8. PubMed ID: 22018764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study protocol of a randomised controlled trial for the effectiveness of a functional partial body weight support treadmill training (FPBWSTT) on motor and functional skills of children with ataxia.
    Lepoura A; Lampropoulou S; Galanos A; Papadopoulou M; Sakellari V
    BMJ Open; 2022 Mar; 12(3):e056943. PubMed ID: 35338064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Video game-based coordinative training improves ataxia in children with degenerative ataxia.
    Ilg W; Schatton C; Schicks J; Giese MA; Schöls L; Synofzik M
    Neurology; 2012 Nov; 79(20):2056-60. PubMed ID: 23115212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent validity of human pose tracking in video for measuring gait parameters in older adults: a preliminary analysis with multiple trackers, viewing angles, and walking directions.
    Mehdizadeh S; Nabavi H; Sabo A; Arora T; Iaboni A; Taati B
    J Neuroeng Rehabil; 2021 Sep; 18(1):139. PubMed ID: 34526074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial.
    Rodríguez-Díaz JC; Velázquez-Pérez L; Rodríguez Labrada R; Aguilera Rodríguez R; Laffita Pérez D; Canales Ochoa N; Medrano Montero J; Estupiñán Rodríguez A; Osorio Borjas M; Góngora Marrero M; Reynaldo Cejas L; González Zaldivar Y; Almaguer Gotay D
    Mov Disord; 2018 Sep; 33(9):1481-1487. PubMed ID: 30132999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cerebellar transcranial alternating current stimulation in cerebellar ataxia: study protocol for a randomised controlled trial.
    Liu X; Lin W; Zhang L; Zhang WL; Cheng XP; Lian YH; Li MC; Wang SZ; Chen XY; Gan SR
    Front Neurosci; 2023; 17():1180454. PubMed ID: 37179566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.
    Fields T; Patterson M; Bremova-Ertl T; Belcher G; Billington I; Churchill GC; Davis W; Evans W; Flint S; Galione A; Granzer U; Greenfield J; Karl R; Kay R; Lewi D; Mathieson T; Meyer T; Pangonis D; Platt FM; Tsang L; Verburg C; Factor M; Strupp M
    Trials; 2021 Jan; 22(1):84. PubMed ID: 33482890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the dynamic gait index a useful outcome to measure balance and ambulation in patients with cerebellar ataxia?
    Reoli R; Therrien A; Cherry-Allen K; Keller J; Millar J; Bastian A
    Gait Posture; 2021 Sep; 89():200-205. PubMed ID: 34333242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Rivastigmine on Patients with Spinocerebellar Ataxia Type 3: A Case Series of Five Patients.
    Grobe-Einsler M; Vogt IR; Schaprian T; Hurlemann R; Klockgether T; Kaut O
    Neurodegener Dis; 2020; 20(2-3):104-109. PubMed ID: 32992315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia Type 3: a Randomized, Double-Blind, Sham-Controlled Trial.
    Maas RPPWM; Teerenstra S; Toni I; Klockgether T; Schutter DJLG; van de Warrenburg BPC
    Neurotherapeutics; 2022 Jul; 19(4):1259-1272. PubMed ID: 35501469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.